Glassy cell carcinoma of the cervix - Cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu protein

被引:10
|
作者
Kuroda, Hajime [1 ]
Toyozumi, Yasuo [1 ]
Masuda, Tomoko [1 ]
Ougida, Tomohiko [1 ]
Hanami, Kyota [1 ]
Kyoko, Kiuchi [1 ]
Tamaru, Jun-ichi [1 ]
Itoyama, Shinji [1 ]
机构
[1] Saitama Med Sch, Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan
关键词
cervical cancer; estrogen; progesterone; Her2/neu protein; glassy cell carcinoma;
D O I
10.1159/000325985
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective To analyze the cytologic features, estrogen and progesterone receptors, and Her2/neu protein in glassy cell carcinoma (GCC) of the cervix. Study Design Cases were analyzed using various parameters, including age at presentation, stage, treatment and clinical course. Between 1990 and 2003, patients with primary cervical carcinomas were treated and cytopathologic analyses performed. Tests for estrogen receptor (ER), progesterone receptor (PR) and her2/neu protein were performed on paraffin sections. Results GCC of the cervix is composed of large cells with abundant chromatin, which gives them their characteristic glassy appearance. Eleven cases were identified as GCC. One case (9.1%) was correctly diagnosed from the cervicovaginal smear. Among the GCC cases, ER. PR and Her2/neu were positive in 2(18.1%), 1 (9.1%) and 5(45.4%) cases, respectively. Conclusion Cytology of GCC reveals characteristic features that differ from those of other carcinomas of the cervix. GCC has unique cytologic characteristics and causes diagnostic confusion, possibly leading to incorrect diagnoses. The reason for such low diagnostic precision in cytology might be due to the lack of differentation and low frequency of this tumor. Our results, demonstrating Her2/neu overexpression, may correlate with more aggressive behavior and a worse clinical outcome.
引用
收藏
页码:418 / 422
页数:5
相关论文
共 50 条
  • [1] Glassy cell carcinoma of the uterine cervix -: Cytologic features and expression of estrogen and progesterone receptors
    Chung, JH
    Koh, JS
    Lee, SS
    Cho, KJ
    ACTA CYTOLOGICA, 2000, 44 (04) : 551 - 556
  • [2] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    LABORATORY INVESTIGATION, 2006, 86 : 21A - 21A
  • [3] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    MODERN PATHOLOGY, 2006, 19 : 21A - 21A
  • [4] Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression
    Alshenawy, Hanan AlSaeid
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2012, 24 (02) : 77 - 83
  • [5] Expression of estrogen and progesterone receptors and Her2/Neu oncogene in breast carcinoma: Correlation between cytologic and surgical specimens
    Sullivan, KE
    Cohen, C
    Chakraborty, H
    Battles, OE
    MODERN PATHOLOGY, 2001, 14 (01) : 63A - 63A
  • [6] Breast Cancer Biomarkers Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation
    Jorns, Julie M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (12) : 1444 - 1449
  • [7] Effect of EDTA decalcification on estrogen receptor and progesterone receptor immunohistochemistry and HER2/neu fluorescence in situ hybridization in breast carcinoma
    Washburn, Erik
    Tang, Xiaoyu
    Caruso, Carla
    Walls, Michelle
    Han, Bing
    HUMAN PATHOLOGY, 2021, 117 : 108 - 114
  • [8] HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma
    Ramalho, Susana
    Serra, Katia Piton
    Vassallo, Jose
    Soares, Fernando Augusto
    Pinto, Glauce Aparecida
    Teixeira, Luiz Carlos
    da Cunha, Isabela Werneck
    Derchain, Sophie F. M.
    de Souza, Gustavo
    ACTA HISTOCHEMICA, 2013, 115 (02) : 120 - 127
  • [9] Dynamic MR Imaging of Invasive Ductal Carcinoma: Studying Kinetics by Estrogen Receptor, Progesterone Receptor and Her2/Neu Amplification Status
    Arkani, S.
    Newstead, G.
    Abe, H.
    Shimauchi, A.
    Karczmar, G.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05)
  • [10] Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
    Wang, Caifeng
    Tran, Davis A.
    Fu, Melinda Z.
    Chen, Wei
    Fu, Sidney W.
    Li, Xu
    JOURNAL OF CANCER, 2020, 11 (07): : 1693 - 1701